Mirum Pharmaceuticals Files 2024 10-K
Ticker: MIRM · Form: 10-K · Filed: Feb 26, 2025 · CIK: 1759425
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Mirum Pharma dropped its 2024 10-K. Full financials out now.
AI Summary
Mirum Pharmaceuticals, Inc. filed its 2024 10-K on February 26, 2025, detailing its financial performance and business operations for the fiscal year ending December 31, 2024. The company, incorporated in Delaware, is based in Foster City, California, and operates in the pharmaceutical preparations sector. Key financial data and business segments are outlined in the filing, providing stakeholders with a comprehensive overview of the company's status.
Why It Matters
This filing provides investors and analysts with the official year-end financial statements and operational details for Mirum Pharmaceuticals, crucial for understanding the company's performance and future outlook.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Mirum is subject to significant regulatory, clinical, and market risks inherent in drug development and commercialization.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-02-26 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Mirum Pharmaceuticals, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-26 (date) — Filing date
- Foster City, CA (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code 2834.
When did Mirum Pharmaceuticals, Inc. file its 10-K report?
Mirum Pharmaceuticals, Inc. filed its 10-K report on February 26, 2025.
What fiscal year does this 10-K filing cover?
This 10-K filing covers the fiscal year ending on December 31, 2024.
Where is Mirum Pharmaceuticals, Inc. headquartered?
Mirum Pharmaceuticals, Inc. is headquartered at 989 East Hillsdale Boulevard, Suite 300, Foster City, CA 94404.
What is the SEC file number for Mirum Pharmaceuticals, Inc.?
The SEC file number for Mirum Pharmaceuticals, Inc. is 001-38981.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 26, 2025 regarding Mirum Pharmaceuticals, Inc. (MIRM).